SELLAS Life Sciences Group (SLS) EPS (Weighted Average and Diluted): 2020-2023
Historic EPS (Weighted Average and Diluted) for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to -$1.34.
- SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) rose 41.86% to -$0.25 in Q4 2023 from the same period last year, while for Dec 2023 it was -$1.36, marking a year-over-year increase of 39.01%. This contributed to the annual value of -$1.34 for FY2023, which is 37.09% up from last year.
- SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) amounted to -$1.34 in FY2023, which was up 37.09% from -$2.13 recorded in FY2022.
- Over the past 5 years, SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) peaked at -$1.34 during FY2021, and registered a low of -$2.13 during FY2022.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$1.34 (2023), whereas its average is -$1.60.
- In the last 5 years, SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) plummeted by 58.96% in 2022 and then surged by 37.09% in 2023.
- Over the past 4 years, SELLAS Life Sciences Group's EPS (Weighted Average and Diluted) (Yearly) stood at -$2.11 in 2020, then skyrocketed by 36.49% to -$1.34 in 2021, then crashed by 58.96% to -$2.13 in 2022, then soared by 37.09% to -$1.34 in 2023.